SEATTLE, June 01, 2021, (MEDGADGET) — Overview:
The most common type of mutation in all life forms’ genomes is a single nucleotide polymorphism (SNP). The measurement of genetic variations of SNPs between members of a species is known as SNP genotyping.
Over the forecast period, the global SNP genotyping and analysis market is expected to rise due to the rising prevalence of genetic disorders. For instance, the number of people with cystic fibrosis rose from 21,421 in 2003 to 30,775 in 2018, according to the Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018.
Furthermore, market development is expected to be aided by collaborative efforts to improve personalised medicine. For instance, in April 2020, the Oncology Alliance for Individualized Medicine was launched by Indivumed GmbH, an oncology company, as an international collaborative alliance to advance personalised medicine in cancer through IndivuType, the company’s multi-omics database.
For More Information, Request Sample Copy Of Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/3972
In terms of value, SNP Microarray dominated the global SNP genotyping and analysis market in 2019, with a 37.9% share, led by Taqman Allelic Discrimination and Others, respectively.
Imperfect protocols that result in large amounts of duplicate data are expected to hamper market development. Several fields, such as diagnostics in the genotyping segment, have yet to show themselves to be viable markets. Although SNP genotyping has long been associated with diagnostics, it is currently only used as a research tool in diagnostics, rather than being able to conduct a diagnostic test.
Furthermore, despite the high precision of short read sequencing, misalignment still makes it difficult to obtain correct SNP genotypes at low sequencing coverage and in highly duplicated genomes, which is expected to restrict market growth.
Players in the global SNP genotyping and analysis market should expect lucrative growth opportunities as SNP genotyping becomes more widely used in farm animal gene exploration. For instance, Researchers from the Jung P & C Institute, Inc. in South Korea, for example, used Bayesian methods in various genotyping platforms to conduct genomic analysis in Korean Duroc pigs in April 2020.
Furthermore, the industry is expected to benefit from molecular, retrospective, multicentre cancer research. For instance, in June 2020, a study presented at the virtual Society of Gynaecologic Oncology 2020 Annual Meeting on Women’s Cancer reported analysing a broad clinical dataset of low-grade serous ovarian cancer through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival.
The global SNP genotyping and analysis market was valued at US$ 9,485.2 Mn in 2019 and is forecast to reach a value of US$ 46,268.9 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027.
The global SNP genotyping and analysis market is estimated to account for US$ 11,553.0 Mn in terms of value in 2020 and is expected to reach US$ 46,268.9 Mn by the end of 2027.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3972
SNP Genotyping and Analysis Market, By Technology, is segmented into:
- By Technology:
- SNP Microarray
- Taqman Allelic Discrimination
- SNP Pyrosequencing Technologies
- Sequenom Mass-Array MALDI-TOF
- By Application:
- Pharmaceuticals and Pharmacogenomics
- Diagnostic Research
- Agricultural Biotechnology
- Breeding and Animal Livestock
- By Region:
- North America
- Latin America
- Asia Pacific
- Middle East
Market Trends/Key Takeaways:
The market’s major players are focusing on M&A initiatives to broaden their product range. Fluidigm Corporation, for instance, acquired InstruNor AS, a privately owned supplier of fully integrated sample preparation systems for flow and mass cytometry, in February 2020.
The market’s major players are concentrating their efforts on aimed therapies. For instance, Thermo Fisher Scientific facilitated the next step of the FinnGen precision medicine study, which aims to improve overall understanding of chronic disease mechanisms in the Finnish population, in October 2018.
Key players operating in the global SNP genotyping and analysis market include, Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, LGC Limited, Fluidigm Corporation, Illumina, Inc., and Sequenom, Inc.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/snp-genotyping-and-analysis-market-3240
In July 2019, Customers will be able to genotype canines and felines using three new Applied Biosystems AgriSeq targeted genotyping by sequencing solutions, according to Thermo Fisher Scientific.
Other Related Reports:
Boost in Research Activities to Increase Growth in Global DNA/Gene Microarray Market 2021 – 2027
Boost in Research Activities to Increase Growth in Global Corona Virus Vaccine Market 2021 – 2027
Boost in Research Activities to Increase Growth in Global Biotechnology Market 2021 – 2027
Boost in Research Activities to Increase Growth in Global DNA and RNA Sample Preparation Market 2021 – 2027
Boost in Research Activities to Increase Growth in Global DNA Repair Drugs Market 2021 – 2027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027